Patents by Inventor Henry R. Kranzler

Henry R. Kranzler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genotype-guided dosing of opioid receptor agonists
    Patent number: 10900082
    Abstract: Provided herein, in some aspects, are methods of dosing opioid receptor agonists for treatment of opioid dependence and pain management.
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: January 26, 2021
    Assignees: Yale University, The Trustees of the University of Pennsylvania
    Inventors: Joel Gelernter, Andrew Smith, Henry R. Kranzler
  • GENOTYPE-GUIDED DOSING OF OPIOID RECEPTOR AGONISTS
    Publication number: 20180216188
    Abstract: Provided herein, in some aspects, are methods of dosing opioid receptor agonists for treatment of opioid dependence and pain management.
    Type: Application
    Filed: January 24, 2018
    Publication date: August 2, 2018
    Applicant: Yale University
    Inventors: Joel Gelernter, Andrew Smith, Henry R. Kranzler